
Preformed Line Products Company Income Statement 2025-2008 | PLPC
Brief overview of profit and loss at Preformed Line Products Company
The comparison covers a five-year financial horizon. Preformed Line Products Company reported revenue of $466 million in 2020 and $669 million by 2025. The total change was +43.5%, with a CAGR of approximately 7.5%. Revenue advanced gradually over the five-year period.
The five-year change in gross profit reached +35.4%: from 154 million dollars to 209 million dollars. Direct costs broadly followed the top-line trend. Gross margin moved from 33% to 31.2%. The economics of the core business remained steady.
Over the period, EBITDA shifted from $54 million to $78.2 million, a change of +44.6%. There was no major divergence between EBITDA and revenue. EBITDA margin moved from 11.6% to 11.7%. The operating margin showed no pronounced shift.
Net profit was 29.8 million dollars at the start and 35.3 million dollars at the end. The final result remained comparatively stable.
Market capitalization changed from $334 million to $1.2 billion (+267.8%). Capitalization moved ahead of the business fundamentals.
Conclusion
The financial profile remains mixed, with strengths and risks moving in different directions. The financial profile benefits from a stronger final result, consistent operating efficiency and a larger revenue base. The overall view is constrained by weaker gross profitability. Investors should continue to monitor margins, costs, and earnings quality.
Annual Income Statement Preformed Line Products Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.23 B | 1.23 B | 643 M | 552 M | 317 M | 334 M | 280 M | 280 M | 406 M | 281 M | 202 M | 257 M | 369 M | 360 M | 332 M | 160 M | 241 M | - |
Shares |
4.92 M | 4.91 M | 4.92 M | 4.93 M | 4.91 M | 4.92 M | 5.03 M | 5.03 M | 5.1 M | 5.17 M | 5.35 M | 5.38 M | 5.36 M | 5.32 M | 5.26 M | 5.24 M | 5.23 M | - |
Historical Prices |
250 | 250 | 131 | 112 | 64.7 | 67.9 | 58.9 | 52 | 67.6 | 54.5 | 38.7 | 49.3 | 65 | 52.1 | 51.6 | 30.6 | 46 | 50.1 |
Net Income |
35.3 M | 37.1 M | 63.3 M | 54.4 M | 35.7 M | 29.8 M | 23.3 M | 26.6 M | 12.7 M | 15.3 M | 6.68 M | 12.9 M | 20.6 M | 29.3 M | 31 M | 23.1 M | 23.4 M | - |
Revenue |
669 M | 594 M | 670 M | 637 M | 517 M | 466 M | 445 M | 421 M | 378 M | 337 M | 355 M | 388 M | 410 M | 439 M | 424 M | - | - | - |
Cost of Revenue |
461 M | 404 M | 435 M | 422 M | 351 M | 312 M | 304 M | 289 M | 260 M | 227 M | - | - | - | - | - | - | - | - |
Gross Profit |
209 M | 190 M | 235 M | 215 M | 166 M | 154 M | 141 M | 132 M | 119 M | 109 M | 103 M | 121 M | 131 M | 144 M | 141 M | 108 M | 84.8 M | - |
Operating Income |
55.1 M | 50.8 M | 84.2 M | 69.4 M | 47.5 M | 40.2 M | 32.6 M | 32.9 M | 26.1 M | 21.5 M | 12.3 M | 21.2 M | 31.1 M | 44.1 M | 45.4 M | 28.5 M | 19.5 M | - |
Interest Expense |
1.13 M | -339 K | 3.9 M | 3.21 M | 2.02 M | 2.4 M | 2.22 M | 1.29 M | 1.06 M | 844 K | 565 K | 658 K | 450 K | 597 K | 827 K | 649 K | 523 K | - |
EBITDA |
78.2 M | 71.6 M | 103 M | 85.8 M | 63.1 M | 54 M | 48.7 M | 47.8 M | 39.9 M | 33.5 M | 32.6 M | 39.3 M | 48 M | 57.2 M | 57.8 M | 37.9 M | 26.7 M | - |
Operating Expenses |
- | - | - | - | - | - | 106 M | 96.9 M | 91.5 M | 87.9 M | 82.4 M | 94.5 M | 95 M | 98.8 M | 93.6 M | - | - | - |
General and Administrative Expenses |
75.2 M | 67.5 M | 74.6 M | 70.3 M | 55.3 M | 56.3 M | 51.8 M | 45.4 M | 43.2 M | 42.1 M | 36.9 M | 42.6 M | 44.6 M | 46.2 M | 44.4 M | 39.9 M | 34 M | - |
All numbers in USD currency
Quarterly Income Statement Preformed Line Products Company
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
4.77 M | 4.91 M | 4.92 M | 4.93 M | 4.93 M | 4.91 M | 4.9 M | 4.92 M | 4.92 M | 4.91 M | 4.91 M | 4.94 M | 4.94 M | 4.92 M | 4.94 M | 4.94 M | 4.93 M | 4.91 M | 4.9 M | 4.91 M | 4.92 M | 4.9 M | 4.92 M | 4.97 M | 5.01 M | 4.99 M | 5.02 M | 5.05 M | 5.04 M | 5.02 M | 5.02 M | 5.04 M | 5.05 M | 5.04 M | 5.1 M | 5.12 M | 5.12 M | 5.12 M | 5.15 M | 5.19 M | 5.21 M | 5.22 M | 5.36 M | 5.39 M | 5.4 M | 5.4 M | 5.37 M | 5.39 M | 5.39 M | 5.39 M | 5.36 M | 5.37 M | 5.38 M | 5.38 M | 5.32 K | 5.33 K | 5.33 K | 5.33 M | 5.25 M | 5.26 M | 5.27 M |
Net Income |
21.5 M | 10.5 M | 2.63 M | 12.7 M | 11.5 M | - | 7.68 M | 9.37 M | 9.6 M | - | 15.1 M | 20.5 M | 21.4 M | - | 11.9 M | 13.7 M | 12.3 M | - | 10.7 M | 8.89 M | 7.18 M | - | 13 M | 10.5 M | 3.7 M | 5.62 M | 7.95 M | 7.9 M | 1.82 M | 5.26 M | 9.05 M | 6.74 M | 5.53 M | 702 K | 6.28 M | 4.16 M | 1.52 M | 5.1 M | 4.74 M | 2.76 M | 2.66 M | 3.04 M | 206 K | 3.68 M | -256 K | 2.49 M | 2.56 M | 5.08 M | 2.74 M | 3.13 M | 6.1 M | 6.39 M | 4.96 M | 5.27 M | 9.28 M | 6.6 M | 8.13 M | 8.94 M | 6.66 M | 8.39 M | 7 M |
Revenue |
213 M | 176 M | 178 M | 170 M | 149 M | - | 147 M | 139 M | 141 M | - | 160 M | 182 M | 182 M | - | 165 M | 163 M | 138 M | - | 135 M | 133 M | 118 M | - | 127 M | 118 M | 103 M | 114 M | 119 M | 115 M | 97.2 M | 105 M | 108 M | 109 M | 98.1 M | 96.9 M | 99.2 M | 97.5 M | 84.6 M | - | - | - | - | - | - | - | - | 96.2 M | 102 M | 100 M | 89.9 M | 98.5 M | 101 M | 112 M | 98.7 M | 104 M | 114 M | 112 M | 109 M | 106 M | 109 M | 115 M | 95.1 M |
Cost of Revenue |
140 M | 121 M | 125 M | 114 M | 99.9 M | - | 101 M | 94.4 M | 96.8 M | - | 106 M | 115 M | 116 M | - | 107 M | 111 M | 96.3 M | - | 92.2 M | 90 M | 77.4 M | - | 82.5 M | 78.1 M | 69.9 M | - | 79.9 M | 77 M | 69.9 M | - | 74.9 M | 73.7 M | 66.6 M | - | 65.7 M | 67.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
73 M | 55.2 M | 52.8 M | 55.4 M | 48.7 M | - | 45.8 M | 44.3 M | 44.1 M | - | 54.1 M | 66.3 M | 66.3 M | - | 58.3 M | 52.7 M | 42 M | - | 43.2 M | 43 M | 40.2 M | - | 44.9 M | 39.6 M | 32.9 M | 36.2 M | 39.3 M | 37.8 M | 27.3 M | 32 M | 33.5 M | 35.2 M | 31.5 M | 30.8 M | 33.5 M | 29.7 M | 24.7 M | 29.5 M | 28.9 M | 26.8 M | 24.3 M | 26.1 M | 26.2 M | 26.4 M | 24.8 M | 29.8 M | 32.5 M | 31.2 M | 27.4 M | 30.4 M | 31.7 M | 37.5 M | 31.3 M | 33 M | 38.5 M | 37 M | 36 M | 34.2 M | 37.6 M | 36.7 M | 32.4 M |
Operating Income |
27.9 M | 13.7 M | 13.1 M | 17.1 M | 13.1 M | - | 10.4 M | 11.3 M | 11.6 M | - | 20.1 M | 28.1 M | 29 M | - | 17.4 M | 17.9 M | 9.45 M | - | 13.1 M | 12.7 M | 10.8 M | - | 16.9 M | 14.8 M | 5.15 M | - | 11.6 M | 11.1 M | 2.05 M | - | 8.02 M | 9.33 M | 7.74 M | - | 9.81 M | 6.29 M | 2.26 M | - | 6.62 M | 4.08 M | 3.69 M | - | 2.09 M | 5.18 M | -85 K | - | 5.14 M | 7.61 M | 4.21 M | - | 8.27 M | 10.5 M | 6.87 M | - | 13.2 M | 9.67 M | 12.1 M | - | 10.1 M | 13.1 M | 10.1 M |
Interest Expense |
149 K | 69 K | 510 K | 116 K | 407 K | - | 64 K | 91 K | 35 K | - | 18 K | 1.13 M | 1.07 M | - | 819 K | 784 K | 526 K | - | 559 K | 457 K | 463 K | - | 504 K | 719 K | 709 K | - | 735 K | 585 K | 368 K | - | 364 K | 348 K | 280 K | - | 255 K | 277 K | 299 K | - | 264 K | 166 K | 158 K | - | 141 K | 149 K | 133 K | - | 141 K | 202 K | 161 K | - | 121 K | 105 K | 103 K | - | 144 K | 149 K | 196 K | - | 177 K | 266 K | 211 K |
EBITDA |
40.3 M | 19.9 M | 30 M | - | 18.5 M | - | - | - | 17 M | - | 20.6 M | 28.6 M | 33.3 M | - | 17.9 M | 18.4 M | 12.5 M | - | 23.6 M | 13.2 M | 13.9 M | - | 27 M | 21.5 M | 8.51 M | - | 21.5 M | 17.7 M | 5.19 M | - | 17.3 M | 15.9 M | 11 M | - | 18.9 M | 12.2 M | 5.23 M | - | 15.2 M | 9.68 M | 6.4 M | - | 11.2 M | 11.4 M | 3.16 M | - | 14.7 M | 13.9 M | 7.29 M | - | 17.3 M | 16.6 M | 9.83 M | - | 21.4 M | 15.1 M | 14.8 M | - | 17.7 M | 18.2 M | 12.6 M |
General and Administrative Expenses |
21.5 M | 21.1 M | 19.1 M | 18.7 M | 17.6 M | - | 16.4 M | 15.2 M | 16.6 M | - | 17.8 M | 18.2 M | 18.6 M | - | 17.5 M | 16.9 M | 16.3 M | - | 14.7 M | 13.8 M | 14.4 M | - | 14 M | 12.4 M | 13.4 M | - | 13.3 M | 12.9 M | 12.3 M | - | 11.7 M | 11.3 M | 10.9 M | - | 11 M | 10.8 M | 10.3 M | - | 10.6 M | 11 M | 10.1 M | - | 8.01 M | 9.39 M | 10.2 M | - | 10.2 M | 10.8 M | 11.2 M | - | 10.4 M | 12.1 M | 11.5 M | - | 12.8 M | 12.1 M | 12 M | - | 12.3 M | 11.8 M | 11 M |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Preformed Line Products Company (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.